Hawi Amale 4
4 · PENWEST PHARMACEUTICALS CO · Filed Mar 8, 2010
Insider Transaction Report
Form 4
Hawi Amale
SVP, Pharmaceutical Dev.
Transactions
- Award
Stock Option Right-to-Buy
2010-03-05+75,000→ 75,000 totalExercise: $3.04From: 2014-03-05Exp: 2020-03-05→ Common Stock (75,000 underlying)
Footnotes (1)
- [F1]The options vest in four equal annual installments with the first installment vesting on 03/05/2011.